Viewing Study NCT02941120


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-03-06 @ 7:57 AM
Study NCT ID: NCT02941120
Status: COMPLETED
Last Update Posted: 2019-12-03
First Post: 2016-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects
Sponsor: Tetec AG
Organization:

Study Overview

Official Title: Retrospective Observational Study for Reconstruction of Localized, Full-thickness Cartilage Defects in the Knee Joint With In-situ Polymerizable and Chondrocyte Populated Biomaterial (NOVOCART® Inject)
Status: COMPLETED
Status Verified Date: 2019-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RENOVO
Brief Summary: Retrospective non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with full-thickness cartilage defects in the knee joint.
Detailed Description: Retrospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with localized full-thickness cartilage defects in the knee joint.

Safety: Measuring the number of adverse drug reactions/serious adverse drug reactions since treatment and up to the present time.

Efficacy: Evaluate symptoms and functional status at the present time using IKDC 2000 (International Knee Documentation Committee) and KOOS (Knee injury osteoarthritis outcome score).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: